CITY-FXI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CITY-FXI, covering 2026-02-24 to 2026-02-24. Get the full timeline:
Most recent: Clinical Trial Update: A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults and Adults With FV Leiden or Prothrombin G20210A Mutation [Phase 1]